MedTrace Logo

Prognostic Value of Plasma DPP4 Activity in ST-elevation Myocardial Infarction Patients

NCT03046576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 625

Last updated 2017-07-21

No results posted yet for this study

Summary

Increased plasma DPP4 activity (DPP4a) could predict both subclinical and new-onset atherosclerosis, and our previous study has found that the DPP4a was significantly lower in MI patients compared with patients having chest pain or unstable angina alone, and DPP4a is associated with no-reflow and major bleeding events in STEMI patients during hospital stay. As no-reflow phenomenon and major bleeding events independently associates with a worse in-hospital and long-term prognosis. One may speculate that the DPP4a is associated with long-term follow-up adverse cardiovascular events in these patients.The hypothesis was tested in this study.

Conditions

  • Coronary Angiography
  • Dipeptidyl Peptidase 4

Interventions

DIAGNOSTIC_TEST

plasma DPP4 activity

DPP4a was determined by enzymatic assays.

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2015-09-30
Completion
2015-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03046576 on ClinicalTrials.gov